Sintillumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sintillumab, covering 2024-07-03 to 2024-07-03. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC [Phase 3]